Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Pramlintide acetate price?
Does lipitor's effectiveness decrease with high fat meals?
Bivalirudin manufacturer?
Pramlintide fda approval date?
The expiration date of the key patent for guselkumab?

Fda orange book.?

What is the FDA’s Orange Book?
The “Orange Book” (officially Approved Drug Products with Therapeutic Equivalence Evaluations) is the U.S. Food and Drug Administration’s publicly‑available database that lists:

What it contains Why it matters
Approved drug products (brand‑name and generic) Shows what has received an FDA “approval” (not just clearance)
Therapeutic equivalence information Gives each drug a therapeutic equivalence code (1–4 or “Not Equiv.”) that tells you whether a generic can be substituted for a brand drug
Patent and exclusivity data Highlights patents still in force and the exclusivity periods that can delay generic entry
Regulatory status & approval dates Lets you see how long a product has been on the market
Product and formulation details Helps pharmacists, clinicians, and insurers identify the exact product (e.g., dose, strength, form)

The Orange Book is updated monthly and is freely accessible online. It is used by:

  • Pharmacists to check whether a generic is interchangeable with a brand name.
  • Health insurers & PBMs to determine formulary placement and cost‑sharing.
  • Regulators & industry to track patent expirations, exclusivity periods, and pending generic approvals.

How to use the Orange Book

  1. Go to the FDA’s Orange Book site
    https://www.accessdata.fda.gov/scripts/cder/ob/

  2. Search options

    • Generic name (e.g., metformin)
    • Brand name (e.g., Glucophage)
    • Active ingredient + strength
    • Drug code (unique identifier)

  3. Read the results

    • The Therapeutic Equivalence Code is key:
      • Code 1 – Drugs are considered interchangeable (therapeutically equivalent).
      • Code 2 – Some, but not all, generic drugs are considered interchangeable.
      • Code 3 – Drugs are not considered interchangeable.
      • Code 4 – Drugs are considered interchangeable only when certain conditions are met (rare).
      • “Not Equiv.” – No generic has been evaluated for equivalence yet.

  4. Check patents & exclusivity

    • The table lists patent expiration dates and exclusivity periods (e.g., 5‑year exclusivity for new molecular entities).
    • This information is crucial for predicting when generics may become available.

  5. Export or print

    • You can export search results to a spreadsheet or print a summary for your records.

Quick FAQ

Question Answer
Is the Orange Book the same as the Orange Book from the USP? No. The FDA Orange Book is a regulatory database. The USP’s Orange Book (United States Pharmacopeia) is a compendium of drug standards, but they share a color name.
Does the Orange Book guarantee a generic can be substituted? Not entirely. A Code 1 indicates regulatory equivalence, but state laws and insurance formularies may still restrict substitution.
Can I find the most recent approvals here? Yes. The database is updated monthly; the “New Product” tab shows the latest approvals.
How do patents in the Orange Book relate to brand names? Patents are linked to the brand product and list the exclusivity period that protects the brand from generic competition.
What if I see “Not Equiv.” for a drug? It means the FDA has not yet evaluated the generic for therapeutic equivalence. A generic may still be on the market if the FDA has accepted a generic application, but substitution isn’t guaranteed.

Why It Matters to Patients & Providers

  • Cost savings: Knowing whether a generic is therapeutically equivalent helps patients and payers switch to lower‑price options.
  • Safety assurance: The therapeutic equivalence assessment gives confidence that a generic will perform the same as its brand counterpart.
  • Drug access planning: Patents and exclusivity dates inform clinicians and pharmacies when a brand drug may be replaced by a generic, affecting formulary management.

Feel free to ask if you’d like help searching for a particular drug or interpreting a specific entry in the Orange Book!



Other Questions About Orange :

pembrolizumab orangebook patents Fda orange book thymosin beta 4? What is the effect of orange juice on lipitor absorption? Book orange filetype pdf? Fda orange book ozempic semaglutide patents? Can i drink orange juice if i take lipitor? Orange book 101 pdf?